Source:http://linkedlifedata.com/resource/pubmed/id/16461044
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2006-2-7
|
pubmed:abstractText |
We sought to investigate the effects of 2 different coronary drug-eluting stents on the distribution of central or effector memory T cells circulating in the coronary sinus of patients with coronary artery disease who underwent percutaneous coronary revascularization. We randomly assigned 43 patients (mean age 65.4 +/- 4.3 years; 34 men) presenting with stable coronary disease and angiographically proved stenosis of the left anterior descending artery to treatment with sirolimus- or paclitaxel-eluting stents. Heparinized blood samples were obtained from the coronary sinus before and 20 minutes after stent implantation. Analysis of surface phenotype was performed by 4-color flow cytometry, and data are expressed as the percentage of positive cells. The percentages of CD8+ and CD4+ effector memory T cells, as defined by the CD3+CD45RO+CD27- phenotype, were significantly reduced in patients who received a sirolimus-eluting stent compared with the basal values. Conversely, the percentages of CD8+, but not CD4+, central memory T cells (CD3+CD45RO+CD27+) were increased in the same treatment group after the revascularization procedure. No changes in the percentages of memory T-cell populations in the paclitaxel-eluting stent group were observed. These findings show that sirolimus-eluting stents rapidly induced a redistribution of memory T lymphocytes, with a significant decrease of proinflammatory effector memory T cells circulating within the coronary sinus.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0002-9149
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
97
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
494-8
|
pubmed:meshHeading |
pubmed-meshheading:16461044-Aged,
pubmed-meshheading:16461044-CD4-Positive T-Lymphocytes,
pubmed-meshheading:16461044-CD8-Positive T-Lymphocytes,
pubmed-meshheading:16461044-Coronary Disease,
pubmed-meshheading:16461044-Female,
pubmed-meshheading:16461044-Flow Cytometry,
pubmed-meshheading:16461044-Humans,
pubmed-meshheading:16461044-Immunosuppressive Agents,
pubmed-meshheading:16461044-Male,
pubmed-meshheading:16461044-Middle Aged,
pubmed-meshheading:16461044-Paclitaxel,
pubmed-meshheading:16461044-Sirolimus,
pubmed-meshheading:16461044-Stents,
pubmed-meshheading:16461044-T-Lymphocyte Subsets
|
pubmed:year |
2006
|
pubmed:articleTitle |
Comparison between sirolimus- and paclitaxel-eluting stent in T-cell subsets redistribution.
|
pubmed:affiliation |
Dipartimento di Scienze Cardiovascolari e Respiratorie, Università La Sapienza, Rome, Italy. rino.sardella@uniroma1.it
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|